Compare Illumina, Inc. (ILMN) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Kyndryl Holdings Inc — how do they compare? Illumina, Inc. trades at $268.39 (market cap $39.95B), while Kyndryl Holdings Inc trades at $11.95 (market cap $2.59B). The key difference: Illumina, Inc. is far larger — about 15.4× Kyndryl Holdings Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Kyndryl Holdings Inc for 36 Days on average.
| ILMN | KD | |
|---|---|---|
Market Cap | $39.95B | $2.59B |
Volume | 3,169,503 | 5,354,348 |
Sector | Health | Technology |
52-Week High | $293.69 | $29.76 |
52-Week Low | $91.00 | $10.59 |
Typical Hold Time | 83 Days | 36 Days |
Enterprise Value | $41.31B | $5.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.
Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.
Kyndryl (KD) trades at $11.45, down 0.26% on the day, reflecting a challenging technical and fundamental environment. The stock exhibits a bearish technical signal with key support at $11 and resistance at $12, while recent earnings misses in Q4 2025 and Q1 2026 contrast with a beat in Q2 2026. Despite a low P/S ratio of 0.18 and positive net income of $252 million in 2025, the company's revenue has declined from $18.3B in 2022 to $15.1B in 2025. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and the acquisition of Healthcare IT Leaders.
The outlook for KD is mixed, with a consensus price target of $14.67 suggesting potential upside, but analyst sentiment is cautious with 71% hold ratings. Key opportunities include AI-driven growth and improving profitability, while risks involve persistent revenue declines, high debt levels, and competitive pressures in the IT services sector. Execution on AI initiatives and future earnings performance will be critical for stock appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
